Date of Report (Date of Earliest Event Reported): | May 2, 2023 |
Ohio | 000-20557 | 34-1562374 | ||||||||||||
(State of incorporation or organization) | (Commission File Number) | (I.R.S. Employer Identification No.) |
Title of each class: | Trading Symbol | Name of each exchange on which registered: | ||||||||||||
Common stock, $0.00 par value, $0.01 stated value | ANDE | The NASDAQ Stock Market LLC |
Exhibit No. | Description | |||||||
99.1 | ||||||||
104 | Inline XBRL for the cover page of this Current Report on Form 8-K |
The Andersons, Inc. | |||||||||||
May 2, 2023 | By: | /s/ Brian A. Valentine | |||||||||
Brian A. Valentine | |||||||||||
Executive Vice President and Chief Financial Officer |
$ in millions, except per share amounts | |||||||||||
Q1 2023 |
Q1 2022 |
Variance | |||||||||
Pretax Income (Loss) from Continuing Operations | $ | (65.0) | $ | 10.6 | $ | (75.6) | |||||
Pretax Income (Loss) from Continuing Operations Attributable to the Company1 |
(20.6) | 10.2 | (30.8) | ||||||||
Adjusted Pretax Income (Loss) from Continuing Operations Attributable to the Company1 |
8.1 | 10.2 | (2.1) | ||||||||
Trade1 |
23.6 | 3.7 | 19.9 | ||||||||
Renewables1 |
6.3 | 5.5 | 0.8 | ||||||||
Nutrient & Industrial | (10.4) | 10.7 | (21.1) | ||||||||
Other | (11.4) | (9.8) | (1.6) | ||||||||
Net Income (Loss) from Continuing Operations Attributable to the Company |
(14.8) | 6.1 | (20.9) | ||||||||
Adjusted Net Income from Continuing Operations Attributable to the Company1 |
6.8 | 6.1 | 0.7 | ||||||||
Diluted Earnings (Loss) Per Share from Continuing Operations (EPS) | (0.44) | 0.18 | (0.62) | ||||||||
Adjusted Diluted Earnings Per Share from Continuing Operations1 |
0.20 | 0.18 | 0.02 | ||||||||
EBITDA from Continuing Operations1 |
(16.2) | 55.8 | (72.0) | ||||||||
Adjusted EBITDA from Continuing Operations1 |
$ | 55.3 | $ | 55.8 | $ | (0.5) | |||||
1 Non-GAAP financial measures; see appendix for explanations and reconciliations. |
Three months ended March 31, | |||||||||||
(in thousands, except per share data) | 2023 | 2022 | |||||||||
Sales and merchandising revenues | $ | 3,881,238 | $ | 3,977,954 | |||||||
Cost of sales and merchandising revenues | 3,733,227 | 3,858,419 | |||||||||
Gross profit | 148,011 | 119,535 | |||||||||
Operating, administrative and general expenses | 117,235 | 101,987 | |||||||||
Asset impairment | 87,156 | — | |||||||||
Interest expense, net | 16,625 | 10,859 | |||||||||
Other income, net | 8,004 | 3,918 | |||||||||
Income (loss) before income taxes from continuing operations | (65,001) | 10,607 | |||||||||
Income tax provision (benefit) from continuing operations | (5,884) | 4,103 | |||||||||
Net income (loss) from continuing operations | (59,117) | 6,504 | |||||||||
Loss from discontinued operations, net of income taxes | — | (554) | |||||||||
Net income (loss) | (59,117) | 5,950 | |||||||||
Net income (loss) attributable to noncontrolling interests | (44,367) | 447 | |||||||||
Net income (loss) attributable to The Andersons, Inc. | $ | (14,750) | $ | 5,503 | |||||||
Earnings (loss) per share attributable to The Andersons, Inc. common shareholders: | |||||||||||
Basic earnings (loss): | |||||||||||
Continuing operations | $ | (0.44) | $ | 0.18 | |||||||
Discontinued operations | — | (0.02) | |||||||||
$ | (0.44) | $ | 0.16 | ||||||||
Diluted earnings (loss): | |||||||||||
Continuing operations | $ | (0.44) | $ | 0.18 | |||||||
Discontinued operations | — | (0.02) | |||||||||
$ | (0.44) | $ | 0.16 |
(in thousands) | March 31, 2023 | December 31, 2022 | March 31, 2022 | ||||||||||||||
Assets | |||||||||||||||||
Current assets: | |||||||||||||||||
Cash and cash equivalents | $ | 70,853 | $ | 115,269 | $ | 36,381 | |||||||||||
Accounts receivable, net | 1,125,071 | 1,248,878 | 1,050,259 | ||||||||||||||
Inventories | 1,551,101 | 1,731,725 | 1,950,303 | ||||||||||||||
Commodity derivative assets – current | 222,036 | 295,588 | 769,916 | ||||||||||||||
Current assets held-for-sale | — | 2,871 | 20,255 | ||||||||||||||
Other current assets | 81,407 | 71,622 | 113,589 | ||||||||||||||
Total current assets | 3,050,468 | 3,465,953 | 3,940,703 | ||||||||||||||
Other assets: | |||||||||||||||||
Goodwill | 129,342 | 129,342 | 129,342 | ||||||||||||||
Other intangible assets, net | 95,134 | 100,907 | 111,055 | ||||||||||||||
Right of use assets, net | 59,209 | 61,890 | 51,821 | ||||||||||||||
Other assets held-for-sale | — | — | 45,264 | ||||||||||||||
Other assets, net | 89,174 | 87,175 | 92,506 | ||||||||||||||
Total other assets | 372,859 | 379,314 | 429,988 | ||||||||||||||
Property, plant and equipment, net | 678,717 | 762,729 | 772,245 | ||||||||||||||
Total assets | $ | 4,102,044 | $ | 4,607,996 | $ | 5,142,936 | |||||||||||
Liabilities and equity | |||||||||||||||||
Current liabilities: | |||||||||||||||||
Short-term debt | $ | 638,210 | $ | 272,575 | $ | 1,449,768 | |||||||||||
Trade and other payables | 768,872 | 1,423,633 | 741,124 | ||||||||||||||
Customer prepayments and deferred revenue | 309,546 | 370,524 | 384,723 | ||||||||||||||
Commodity derivative liabilities – current | 107,983 | 98,519 | 216,836 | ||||||||||||||
Current maturities of long-term debt | 85,567 | 110,155 | 54,158 | ||||||||||||||
Current liabilities held-for-sale | — | — | 10,200 | ||||||||||||||
Accrued expenses and other current liabilities | 202,133 | 245,916 | 205,958 | ||||||||||||||
Total current liabilities | 2,112,311 | 2,521,322 | 3,062,767 | ||||||||||||||
Long-term lease liabilities | 35,727 | 37,147 | 31,419 | ||||||||||||||
Long-term debt, less current maturities | 486,892 | 492,518 | 571,181 | ||||||||||||||
Deferred income taxes | 54,391 | 64,080 | 68,437 | ||||||||||||||
Other long-term liabilities held-for-sale | — | — | 14,738 | ||||||||||||||
Other long-term liabilities | 66,311 | 63,160 | 77,173 | ||||||||||||||
Total liabilities | 2,755,632 | 3,178,227 | 3,825,715 | ||||||||||||||
Total equity | 1,346,412 | 1,429,769 | 1,317,221 | ||||||||||||||
Total liabilities and equity | $ | 4,102,044 | $ | 4,607,996 | $ | 5,142,936 |
Three months ended March 31, | |||||||||||
(in thousands) | 2023 | 2022 | |||||||||
Operating Activities | |||||||||||
Net income (loss) from continuing operations | $ | (59,117) | $ | 6,504 | |||||||
Loss from discontinued operations, net of income taxes | — | (554) | |||||||||
Net income (loss) | (59,117) | 5,950 | |||||||||
Adjustments to reconcile net income (loss) to cash used in operating activities: | |||||||||||
Depreciation and amortization | 32,220 | 34,377 | |||||||||
Bad debt expense, net | — | 1,255 | |||||||||
Stock-based compensation expense | 2,596 | 1,818 | |||||||||
Deferred federal income tax | (8,051) | (6,947) | |||||||||
Asset impairment | 87,156 | — | |||||||||
Other | 3,225 | 3,048 | |||||||||
Changes in operating assets and liabilities: | |||||||||||
Accounts receivable | 125,113 | (215,012) | |||||||||
Inventories | 178,010 | (136,820) | |||||||||
Commodity derivatives | 83,148 | (277,761) | |||||||||
Other current and non-current assets | (17,543) | (38,810) | |||||||||
Payables and other current and non-current liabilities | (760,292) | (446,096) | |||||||||
Net cash used in operating activities | (333,535) | (1,074,998) | |||||||||
Investing Activities | |||||||||||
Purchases of property, plant and equipment and capitalized software | (25,470) | (20,722) | |||||||||
Purchases of investments | — | (1,333) | |||||||||
Purchases of Rail assets | — | (3,186) | |||||||||
Proceeds from sale of Rail assets | 2,871 | 248 | |||||||||
Other | 2,792 | 72 | |||||||||
Net cash used in investing activities | (19,807) | (24,921) | |||||||||
Financing Activities | |||||||||||
Net receipts under short-term lines of credit | 363,619 | 796,209 | |||||||||
Proceeds from issuance of short-term debt | — | 350,000 | |||||||||
Payments of short-term debt | — | (200,000) | |||||||||
Payments of long-term debt | (30,251) | (7,566) | |||||||||
Contributions from noncontrolling interest owner | — | 2,450 | |||||||||
Distributions to noncontrolling interest owner | (9,980) | (9,980) | |||||||||
Payments of debt issuance costs | (5) | (7,310) | |||||||||
Dividends paid | (6,279) | (6,144) | |||||||||
Proceeds from exercises of stock options | — | 5,024 | |||||||||
Common stock repurchased | (1,671) | — | |||||||||
Value of shares withheld for taxes | (6,616) | (3,319) | |||||||||
Other | — | 393 | |||||||||
Net cash provided by financing activities | 308,817 | 919,757 | |||||||||
Effect of exchange rates on cash and cash equivalents | 109 | 99 | |||||||||
Decrease in cash and cash equivalents | (44,416) | (180,063) | |||||||||
Cash and cash equivalents at beginning of period | 115,269 | 216,444 | |||||||||
Cash and cash equivalents at end of period | $ | 70,853 | $ | 36,381 |
Three months ended March 31, | |||||||||||
(in thousands, except per share data) | 2023 | 2022 | |||||||||
Net income (loss) from continuing operations | $ | (59,117) | $ | 6,504 | |||||||
Net income (loss) attributable to noncontrolling interests | (44,367) | 447 | |||||||||
Net income (loss) from continuing operations attributable to The Andersons, Inc. | (14,750) | 6,057 | |||||||||
Adjustments: | |||||||||||
Transaction related compensation | 1,668 | — | |||||||||
Asset Impairment | 44,450 | — | |||||||||
Insurance proceeds and receivables | (17,390) | — | |||||||||
Income tax impact of adjustments1 |
(7,182) | — | |||||||||
Total adjusting items, net of tax | 21,546 | — | |||||||||
Adjusted net income from continuing operations attributable to The Andersons, Inc. | $ | 6,796 | $ | 6,057 | |||||||
Diluted earnings (loss) per share from continuing operations attributable to The Andersons, Inc. common shareholders | $ | (0.44) | $ | 0.18 | |||||||
Impact on diluted earnings (loss) per share from continuing operations | $ | 0.64 | $ | — | |||||||
Adjusted diluted earnings per share from continuing operations | $ | 0.20 | $ | 0.18 |
(in thousands) | Trade | Renewables | Nutrient & Industrial | Other | Total | ||||||||||||||||||||||||
Three months ended March 31, 2023 | |||||||||||||||||||||||||||||
Sales and merchandising revenues | $ | 2,877,780 | $ | 839,516 | $ | 163,942 | $ | — | $ | 3,881,238 | |||||||||||||||||||
Gross profit | 117,178 | 15,803 | 15,030 | — | 148,011 | ||||||||||||||||||||||||
Operating, administrative and general expenses | 71,980 | 8,904 | 24,132 | 12,219 | 117,235 | ||||||||||||||||||||||||
Other income, net | 5,983 | 841 | 846 | 334 | 8,004 | ||||||||||||||||||||||||
Income (loss) before income taxes from continuing operations | 39,364 | (82,513) | (10,438) | (11,414) | (65,001) | ||||||||||||||||||||||||
Loss attributable to noncontrolling interests | — | (44,367) | — | — | (44,367) | ||||||||||||||||||||||||
Income (loss) before income taxes from continuing operations attributable to The Andersons, Inc.1 |
$ | 39,364 | $ | (38,146) | $ | (10,438) | $ | (11,414) | $ | (20,634) | |||||||||||||||||||
Adjustments to income (loss) before income taxes from continuing operations2 |
(15,722) | 44,450 | — | — | 28,728 | ||||||||||||||||||||||||
Adjusted income (loss) before income taxes from continuing operations attributable to The Andersons, Inc.1 |
$ | 23,642 | $ | 6,304 | $ | (10,438) | $ | (11,414) | $ | 8,094 | |||||||||||||||||||
Three months ended March 31, 2022 | |||||||||||||||||||||||||||||
Sales and merchandising revenues | $ | 3,084,681 | $ | 683,231 | $ | 210,042 | $ | — | $ | 3,977,954 | |||||||||||||||||||
Gross profit | 67,619 | 15,191 | 36,725 | — | 119,535 | ||||||||||||||||||||||||
Operating, administrative and general expenses | 59,543 | 7,890 | 25,325 | 9,229 | 101,987 | ||||||||||||||||||||||||
Other income (loss), net | 3,780 | 428 | 804 | (1,094) | 3,918 | ||||||||||||||||||||||||
Income (loss) before income taxes from continuing operations | 3,669 | 5,962 | 10,743 | (9,767) | 10,607 | ||||||||||||||||||||||||
Income attributable to noncontrolling interests | — | 447 | — | — | 447 | ||||||||||||||||||||||||
Income (loss) before income taxes from continuing operations attributable to The Andersons, Inc.1 |
$ | 3,669 | $ | 5,515 | $ | 10,743 | $ | (9,767) | $ | 10,160 | |||||||||||||||||||
1 Income (loss) from continuing operations before income taxes attributable to The Andersons, Inc. for each operating segment is defined as net sales and merchandising revenues plus identifiable other income less all identifiable operating expenses, including interest expense for carrying working capital and long-term assets and is reported net of the noncontrolling interest share of income.
2 Additional information on the individual adjustments that are included in the adjustments to income (loss) from continuing operations before income taxes can be found in the Reconciliation to EBITDA and Adjusted EBITDA table.
|
(in thousands) | Trade | Renewables | Nutrient & Industrial | Other | Total | ||||||||||||||||||||||||
Three months ended March 31, 2023 | |||||||||||||||||||||||||||||
Net income (loss)1 |
$ | 39,364 | $ | (82,513) | $ | (10,438) | $ | (5,530) | $ | (59,117) | |||||||||||||||||||
Interest expense (income) | 11,817 | 3,097 | 2,182 | (471) | 16,625 | ||||||||||||||||||||||||
Tax benefit | — | — | — | (5,884) | (5,884) | ||||||||||||||||||||||||
Depreciation and amortization | 8,645 | 14,472 | 6,957 | 2,146 | 32,220 | ||||||||||||||||||||||||
EBITDA1 |
59,826 | (64,944) | (1,299) | (9,739) | (16,156) | ||||||||||||||||||||||||
Adjusting items impacting EBITDA: | |||||||||||||||||||||||||||||
Transaction related compensation | 1,668 | — | — | — | 1,668 | ||||||||||||||||||||||||
Insurance proceeds & receivables | (17,390) | — | — | — | (17,390) | ||||||||||||||||||||||||
Asset Impairment | — | 87,156 | — | — | 87,156 | ||||||||||||||||||||||||
Total adjusting items | (15,722) | 87,156 | — | — | 71,434 | ||||||||||||||||||||||||
Adjusted EBITDA1 |
$ | 44,104 | $ | 22,212 | $ | (1,299) | $ | (9,739) | $ | 55,278 | |||||||||||||||||||
Three months ended March 31, 2022 | |||||||||||||||||||||||||||||
Net income (loss) from continuing operations | $ | 3,669 | $ | 5,962 | $ | 10,743 | $ | (13,870) | $ | 6,504 | |||||||||||||||||||
Interest expense (income) | 8,187 | 1,767 | 1,461 | (556) | 10,859 | ||||||||||||||||||||||||
Tax provision | — | — | — | 4,103 | 4,103 | ||||||||||||||||||||||||
Depreciation and amortization | 8,974 | 16,639 | 6,579 | 2,185 | 34,377 | ||||||||||||||||||||||||
EBITDA from continuing operations | $ | 20,830 | $ | 24,368 | $ | 18,783 | $ | (8,138) | $ | 55,843 | |||||||||||||||||||
Three Months Ended, | Twelve months ended March 31, 2023 |
||||||||||||||||||||||||||||
(in thousands) | June 30, 2022 | September 30, 2022 | December 31, 2022 | March 31, 2023 | |||||||||||||||||||||||||
Net income (loss) from continuing operations | $ | 102,400 | $ | 24,880 | $ | 21,170 | $ | (59,117) | $ | 89,333 | |||||||||||||||||||
Interest expense | 16,921 | 14,982 | 14,087 | 16,625 | 62,615 | ||||||||||||||||||||||||
Tax provision (benefit) | 15,753 | 9,839 | 9,933 | (5,884) | 29,641 | ||||||||||||||||||||||||
Depreciation and amortization | 33,567 | 33,322 | 33,476 | 32,220 | 132,585 | ||||||||||||||||||||||||
EBITDA from continuing operations | 168,641 | 83,023 | 78,666 | (16,156) | 314,174 | ||||||||||||||||||||||||
Adjusting items impacting EBITDA from continuing operations: | |||||||||||||||||||||||||||||
Transaction related compensation expense | — | — | — | 1,668 | 1,668 | ||||||||||||||||||||||||
Inventory damage (related insurance recoveries) | — | — | 15,993 | (17,390) | (1,397) | ||||||||||||||||||||||||
Asset impairment including equity method investments | 4,455 | — | 9,000 | 87,156 | 100,611 | ||||||||||||||||||||||||
Gain on sale of frac sand assets | (3,762) | — | — | — | (3,762) | ||||||||||||||||||||||||
Total adjusting items | 693 | — | 24,993 | 71,434 | 97,120 | ||||||||||||||||||||||||
Adjusted EBITDA from continuing operations | $ | 169,334 | $ | 83,023 | $ | 103,659 | $ | 55,278 | $ | 411,294 | |||||||||||||||||||
Three Months Ended, | Twelve months ended March 31, 2022 |
||||||||||||||||||||||||||||
June 30, 2021 | September 30, 2021 | December 31, 2021 | March 31, 2022 | ||||||||||||||||||||||||||
Net income from continuing operations | $ | 44,024 | $ | 12,290 | $ | 65,473 | $ | 6,504 | $ | 128,291 | |||||||||||||||||||
Interest expense | 10,060 | 8,799 | 8,444 | 10,859 | 38,162 | ||||||||||||||||||||||||
Tax provision | 9,677 | 4,027 | 11,163 | 4,103 | 28,970 | ||||||||||||||||||||||||
Depreciation and amortization | 38,949 | 42,811 | 36,797 | 34,377 | 152,934 | ||||||||||||||||||||||||
EBITDA from continuing operations | 102,710 | 67,927 | 121,877 | 55,843 | 348,357 | ||||||||||||||||||||||||
Adjusting items impacting EBITDA from continuing operations: | |||||||||||||||||||||||||||||
Transaction related compensation expense | 274 | 243 | 274 | — | 791 | ||||||||||||||||||||||||
Gain on sale of a business | — | (14,619) | — | — | (14,619) | ||||||||||||||||||||||||
Loss from cost method investment | — | 2,784 | — | — | 2,784 | ||||||||||||||||||||||||
Asset impairments | — | — | 8,321 | — | 8,321 | ||||||||||||||||||||||||
Total adjusting items | 274 | (11,592) | 8,595 | — | (2,723) | ||||||||||||||||||||||||
Adjusted EBITDA from continuing operations | $ | 102,984 | $ | 56,335 | $ | 130,472 | $ | 55,843 | $ | 345,634 | |||||||||||||||||||
Three months ended March 31, | |||||||||||
(in thousands) | 2023 | 2022 | |||||||||
Cash used in operating activities | $ | (333,535) | $ | (1,074,998) | |||||||
Changes in operating assets and liabilities | |||||||||||
Accounts receivable | 125,113 | (215,012) | |||||||||
Inventories | 178,010 | (136,820) | |||||||||
Commodity derivatives | 83,148 | (277,761) | |||||||||
Other current and non-current assets | (17,543) | (38,810) | |||||||||
Payables and other current and non-current liabilities | (760,292) | (446,096) | |||||||||
Total changes in operating assets and liabilities | (391,564) | (1,114,499) | |||||||||
Adjusting items impacting cash from operations before working capital changes: | |||||||||||
Less: Damaged inventory insurance proceeds and receivables | (17,390) | — | |||||||||
Cash from operations before working capital changes | $ | 40,639 | $ | 39,501 |